Allied Market Research
Loading...
Cart
0

Close

Upcoming Allied Market Research
2022
Wet Age-related Macular Degeneration (amd) Drugs Market

Wet Age-Related Macular Degeneration (AMD) Drugs Market - Global Opportunity Analysis and Industry Forecast, 2022-2029

LS : Pharmaceuticals
A04483
Pages: NA
Jul 2022 | 2946 Views
   
Author(s) : NA
Tables: NA
Charts: NA

  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.
 
 

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. TOP PLAYER POSITIONING/MARKET SHARE ANALYSIS, 2016
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities

CHAPTER 4 WET AGE-RELATED MACULAR DEGENERATION (AMD) DRUGS MARKET, BY TYPE

4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. LUCENTIS
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast (Value & Volume)
4.2.4. Market size and forecast by region
4.2.5. Market size and forecast by country
4.3. AVASTIN
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast (Value & Volume)
4.3.4. Market size and forecast by region
4.3.5. Market size and forecast by country
4.4. EYLEA
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast (Value & Volume)
4.4.4. Market size and forecast by region
4.4.5. Market size and forecast by country
4.5. OTHER DRUGS
4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast (Value & Volume)
4.5.4. Market size and forecast by region
4.5.5. Market size and forecast by country

CHAPTER 5 WET AGE-RELATED MACULAR DEGENERATION (AMD) DRUGS MARKET, BY END USER

5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. HOSPITALS
5.2.1. Market size and forecast by region
5.2.2. Market size and forecast by country
5.3. OPHTHALMIC CLINICS
5.3.1. Market size and forecast by region
5.3.2. Market size and forecast by country
5.4. RESEARCH INSTITUTES
5.4.1. Market size and forecast by region
5.4.2. Market size and forecast by country
5.5. CONTRACT RESEARCH ORGANIZATIONS
5.5.1. Market size and forecast by region
5.5.2. Market size and forecast by country

CHAPTER 6 WET AGE-RELATED MACULAR DEGENERATION (AMD) DRUGS MARKET, BY REGION

6.1. OVERVIEW
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. North America Wet Age-Related Macular Degeneration (AMD) Drugs Market by Country
6.2.3.1. U.S.
6.2.3.1.1. U.S. Wet Age-Related Macular Degeneration (AMD) Drugs Market by Type
6.2.3.1.2. U.S. Wet Age-Related Macular Degeneration (AMD) Drugs Market by End User
6.2.3.2. Canada
6.2.3.2.1. Canada Wet Age-Related Macular Degeneration (AMD) Drugs Market by Type
6.2.3.2.2. Canada Wet Age-Related Macular Degeneration (AMD) Drugs Market by End User
6.2.3.3. Mexico
6.2.3.3.1. Mexico Wet Age-Related Macular Degeneration (AMD) Drugs Market by Type
6.2.3.3.2. Mexico Wet Age-Related Macular Degeneration (AMD) Drugs Market by End User
6.2.4. North America Wet Age-Related Macular Degeneration (AMD) Drugs Market by Type
6.2.5. North America Wet Age-Related Macular Degeneration (AMD) Drugs Market by End User
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Europe Wet Age-Related Macular Degeneration (AMD) Drugs Market by Country
6.3.3.1. Germany
6.3.3.1.1. Germany Wet Age-Related Macular Degeneration (AMD) Drugs Market by Type
6.3.3.1.2. Germany Wet Age-Related Macular Degeneration (AMD) Drugs Market by End User
6.3.3.2. France
6.3.3.2.1. France Wet Age-Related Macular Degeneration (AMD) Drugs Market by Type
6.3.3.2.2. France Wet Age-Related Macular Degeneration (AMD) Drugs Market by End User
6.3.3.3. UK
6.3.3.3.1. UK Wet Age-Related Macular Degeneration (AMD) Drugs Market by Type
6.3.3.3.2. UK Wet Age-Related Macular Degeneration (AMD) Drugs Market by End User
6.3.3.4. Italy
6.3.3.4.1. Italy Wet Age-Related Macular Degeneration (AMD) Drugs Market by Type
6.3.3.4.2. Italy Wet Age-Related Macular Degeneration (AMD) Drugs Market by End User
6.3.3.5. Spain
6.3.3.5.1. Spain Wet Age-Related Macular Degeneration (AMD) Drugs Market by Type
6.3.3.5.2. Spain Wet Age-Related Macular Degeneration (AMD) Drugs Market by End User
6.3.3.6. Rest of Europe
6.3.3.6.1. Rest of Europe Wet Age-Related Macular Degeneration (AMD) Drugs Market by Type
6.3.3.6.2. Rest of Europe Wet Age-Related Macular Degeneration (AMD) Drugs Market by End User
6.3.4. Europe Wet Age-Related Macular Degeneration (AMD) Drugs Market by Type
6.3.5. Europe Wet Age-Related Macular Degeneration (AMD) Drugs Market by End User
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Asia-Pacific Wet Age-Related Macular Degeneration (AMD) Drugs Market by Country
6.4.3.1. Japan
6.4.3.1.1. Japan Wet Age-Related Macular Degeneration (AMD) Drugs Market by Type
6.4.3.1.2. Japan Wet Age-Related Macular Degeneration (AMD) Drugs Market by End User
6.4.3.2. China
6.4.3.2.1. China Wet Age-Related Macular Degeneration (AMD) Drugs Market by Type
6.4.3.2.2. China Wet Age-Related Macular Degeneration (AMD) Drugs Market by End User
6.4.3.3. Australia
6.4.3.3.1. Australia Wet Age-Related Macular Degeneration (AMD) Drugs Market by Type
6.4.3.3.2. Australia Wet Age-Related Macular Degeneration (AMD) Drugs Market by End User
6.4.3.4. India
6.4.3.4.1. India Wet Age-Related Macular Degeneration (AMD) Drugs Market by Type
6.4.3.4.2. India Wet Age-Related Macular Degeneration (AMD) Drugs Market by End User
6.4.3.5. South Korea
6.4.3.5.1. South Korea Wet Age-Related Macular Degeneration (AMD) Drugs Market by Type
6.4.3.5.2. South Korea Wet Age-Related Macular Degeneration (AMD) Drugs Market by End User
6.4.3.6. Rest of Asia-Pacific
6.4.3.6.1. Rest of Asia-Pacific Wet Age-Related Macular Degeneration (AMD) Drugs Market by Type
6.4.3.6.2. Rest of Asia-Pacific Wet Age-Related Macular Degeneration (AMD) Drugs Market by End User
6.4.4. Asia-Pacific Wet Age-Related Macular Degeneration (AMD) Drugs Market by Type
6.4.5. Asia-Pacific Wet Age-Related Macular Degeneration (AMD) Drugs Market by End User
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. LAMEA Wet Age-Related Macular Degeneration (AMD) Drugs Market by Country
6.5.3.1. Brazil
6.5.3.1.1. Brazil Wet Age-Related Macular Degeneration (AMD) Drugs Market by Type
6.5.3.1.2. Brazil Wet Age-Related Macular Degeneration (AMD) Drugs Market by End User
6.5.3.2. Saudi Arabia
6.5.3.2.1. Saudi Arabia Wet Age-Related Macular Degeneration (AMD) Drugs Market by Type
6.5.3.2.2. Saudi Arabia Wet Age-Related Macular Degeneration (AMD) Drugs Market by End User
6.5.3.3. South Africa
6.5.3.3.1. South Africa Wet Age-Related Macular Degeneration (AMD) Drugs Market by Type
6.5.3.3.2. South Africa Wet Age-Related Macular Degeneration (AMD) Drugs Market by End User
6.5.3.4. Rest of LAMEA
6.5.3.4.1. Rest of LAMEA Wet Age-Related Macular Degeneration (AMD) Drugs Market by Type
6.5.3.4.2. Rest of LAMEA Wet Age-Related Macular Degeneration (AMD) Drugs Market by End User
6.5.4. LAMEA Wet Age-Related Macular Degeneration (AMD) Drugs Market by Type
6.5.5. LAMEA Wet Age-Related Macular Degeneration (AMD) Drugs Market by End User

CHAPTER 7 COMPANY PROFILES

7.1. F. HOFFMANN-LA ROCHE LTD
7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments
7.2. NOVARTIS INTERNATIONAL AG
7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments
7.3. GENENTECH, INC.
7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments
7.4. REGENERON PHARMACEUTICALS, INC.
7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments
7.5. BAYER AG
7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments
7.6. VALEANT PHARMACEUTICALS INTERNATIONAL INC.
7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments
7.7. OPHTHOTECH CORPORATION
7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments
7.8. OHR PHARMACEUTICAL INC.
7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments
7.9. MOLECULAR PARTNERS AG
7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments
7.10. ACUCELA INC.
7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments


 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
PURCHASE OPTIONS

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :		 +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

Connect To Analyst
 

FREQUENTLY ASKED
QUESTIONS?

Read More
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

Request Customization
 

REQUEST TOC/SAMPLE

OR

Purchase Full Report of
Wet Age-related Macular Degeneration (amd) Drugs Market

Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in

  • Enterprise
    License/PDF

  • $9,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2021–2030

Published in Feb 2022

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Lightweight Materials

Read More
 

Rubber

Read More
 

Coatings

Read More
 

Therapeutic

Read More
 

Cancer Drugs

Read More
 

Cable

Read More
 

3D Technology

Read More
 

Electric Motor

Read More
 

Healthcare IT

Read More
 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers